MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
414.61
+8.57
+2.11%
After Hours: 414.80 +0.19 +0.05% 19:53 09/25 EDT
OPEN
408.25
PREV CLOSE
406.04
HIGH
415.20
LOW
404.19
VOLUME
2.21M
TURNOVER
--
52 WEEK HIGH
447.03
52 WEEK LOW
262.49
MARKET CAP
224.15B
P/E (TTM)
25.75
1D
5D
1M
3M
1Y
5Y
1D
2 Healthcare Stocks That Just Delivered Great News for Investors
The Motley Fool · 1d ago
How Phase 3 Sjögren’s Results At Amgen (AMGN) Has Changed Its Investment Story
Simply Wall St · 1d ago
How To Build A $75,000 Dividend Portfolio With SCHD And 5 High-Yield Picks
Seeking Alpha · 2d ago
The Peptide Boom That Isn't About Your Muscles - Heard on the Street
The Wall Street Journal · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)
TipRanks · 2d ago
FDA commissioner nominee Overton rebuffs questions about Trump medical claims
Seeking Alpha · 3d ago
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
Seeking Alpha · 3d ago
Amgen (AMGN) Stock Could Be 40% Undervalued On Phase 3 Sjögren’s Data
Simply Wall St · 3d ago
More
About AMGN
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.